Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome
Conditions
Recurrent Transformed Chronic Lymphocytic Leukemia · Refractory Transformed Chronic Lymphocytic Leukemia · Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma · Recurrent Transformed B-Cell Non-Hodgkin Lymphoma · Recurrent Transformed Non-Hodgkin Lymphoma · Refractory Transformed Non-Hodgkin Lymphoma · Refractory Transformed B-cell Non-Hodgkin Lymphoma · Refractory Transformed
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Principal Investigator (Adam Kittai, MD)Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (Jennifer A Woyach, MD)Huntsman Cancer Institute, Salt Lake City, Utah, United States
Contact: Principal Investigator (Harsh Shah, MD)
Study leads
Jennifer A Woyach, MD
Principal Investigator
Ohio State University Comprehensive Cancer Center